Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > Rising antimicrobial resistance in microbial keratitis post-COVID highlights treatment challenges
  • Cornea and External Disease

Rising antimicrobial resistance in microbial keratitis post-COVID highlights treatment challenges

Kelsey Moroz

Although the overall incidence of microbial keratitis remained stable before, during, and after the COVID-19 pandemic, a significant shift in antimicrobial resistance patterns has occurred, according to a study.

Although some pathogens became less common, those that persisted, particularly fungi, have shown increased resistance.

A new retrospective study analyzed 947 corneal scrape samples from 2018 to 2023, dividing the data into three periods: pre-COVID (2019), COVID-19 (2020-2022), and post-COVID (2023).

Gram-positive bacteria, particularly Staphylococcus epidermidis, dominated across all periods, while Pseudomonas aeruginosa, a Gram-negative bacterium, saw a decrease in incidence after COVID-19. Fungal infections, however, showed a significant increase in the post-COVID period, with Fusarium species becoming more prevalent.

The study concluded that despite a stable overall incidence of microbial keratitis, there is a growing concern about antibiotic resistance, especially among persistent pathogens.

Reference
Haro-Morlett L, Vera-Duarte GR, Oliveros-Valdes F, et al. Effects of the COVID-19 Pandemic on Microbial Keratitis: A 5-Year Comparative Study. Cornea. 2024;doi: 10.1097/ICO.0000000000003720. Epub ahead of print. PMID: 39365354.

Share

Related Content

  • Cornea and External Disease

Quiz: The impact of blepharitis and conjunctivitis on quality of life

  • Dry Eye

Analysis of FDA reports reveals widespread ocular adverse events linked to antidepressants

  • Cornea and External Disease

Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient

  • Retina Care 360

Physical activity shows mixed effects on visual outcomes in type 2 diabetes

  • Trending Topics

AI-based diagnostics show promise for early ocular disease detection

  • Trending Topics

Study explores retinal findings in pregnant women with COVID-19

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon